Sean O'Byrne

Dr. Sean O'Byrne

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
SOSean O'Byrne
Sean O'Byrne
John ScottJohn Scott
John Scott
JPJoseph R. Pilotte
Joseph R. Pilotte
ASAndré da S. Santiago
André da S. Santiago
CLChristopher G. Langendorf
Christopher G. Langendorf
David DrewryDavid Drewry
David Drewry
The calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) activates CAMK1, CAMK4, AMPK, and AKT, leading to numerous physiological responses. The deregulation of CAMKK2 is linked to several diseases, suggesting the utility of CAMKK2 inhibitors for oncological, metabolic and inflammatory indications. In this work, we demonstrate that STO-609, frequently described as a selective inhibitor for CAMKK2, potently inhibits a significant number of other kinases. Through an analysis of literature and public databases, we have identified other potent CAMKK2 inhibitors and verified their activities in differential scanning fluorimetry and enzyme inhibition assays. These inhibitors are potential starting points for the development of selective CAMKK2 inhibitors and will lead to tools that delineate the roles of this kinase in disease biology.

11 January 2023 in Cells
Verified
Journal Article
Open access
PDF file
CWCarrow Wells
Carrow Wells
YLYi Liang
Yi Liang
TPThomas Loyd Pulliam
Thomas Loyd Pulliam
CLChenchu Lin
Chenchu Lin
DADominik Awad
Dominik Awad
David DrewryDavid Drewry
David Drewry
The serine/threonine protein kinase calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) plays critical roles in a range of biological processes. Despite its importance, only a handful of inhibitors of CAMKK2 have been disclosed. Having a selective small molecule tool to interrogate this kinase will help demonstrate that CAMKK2 inhibition can be therapeutically beneficial. Herein, we disclose SGC-CAMKK2-1, a selective chemical probe that targets CAMKK2.

8 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SOSean O'Byrne
Sean O'Byrne
John ScottJohn Scott
John Scott
JPJoseph R. Pilotte
Joseph R. Pilotte
ASAndré de S. Santiago
André de S. Santiago
CLChristopher G. Langendorf
Christopher G. Langendorf
David DrewryDavid Drewry
David Drewry
The calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) plays a central role in many cell signaling pathways. CAMKK2 activates CAMK1, CAMK4, AMPK, and AKT leading to numerous physiological responses. Deregulation of CAMKK2 is linked to several diseases, suggesting utility of CAMKK2 inhibitors for oncological, metabolic and inflammatory indications. In this work we review the role of CAMKK2 in biology and disease. Through analysis of literature and public databases we have identified starting points for CAMKK2 inhibitor medicinal chemistry campaigns. These starting points provide an opportunity for the development of selective CAMKK2 inhibitors and will lead to tools that delineate the roles of this kinase in disease biology.

12 March 2021 in Chemical Communications
Verified
Journal Article
Open access
PDF file
SCStuart T. Caldwell
Stuart T. Caldwell
SOSean O'Byrne
Sean O'Byrne
WCWilson Calum
Wilson Calum
FCFilip Cvetko
Filip Cvetko
MMMichael P. Murphy
Michael P. Murphy
RHRichard C. Hartley
Richard C. Hartley
Photocaged sulfonate delivers membrane impermeant compounds to cells.

13 March 2026 in SLAS Technology
Verified
Journal Article
Open access
IGIrene Georgiou
Irene Georgiou
SOSandra O’NEill
Sandra O’NEill
CRColin Robinson
Colin Robinson
FCFraser Cunningham
Fraser Cunningham
SOSean O'Byrne
Sean O'Byrne
DSDuncan E. Scott
Duncan E. Scott
Different biochemical assays yield different rates of false positives than others either due to the nature of the enzyme, the technology associated with the bioassay, or properties of the compounds being screened. Ensuring that the right counter-screens are in place to identify false positives without wasting time and resources on them is of great importance. Herein we describe the results of a high throughput screen (HTS) against non-structural protein 3 (nsp3) protease PLPro, which resulted exclusively in false-positive hits. By triaging hit compounds through purification of metal chelating resin, we identified contamination by either copper or palladium as the most likely source of false positives from the library screening campaign. We then performed a systematic assessment of the vulnerability of nsp3 protease screening to metal contamination and evaluated common additives to combat the inhibitory effects of different metal salts. We further conducted a thorough survey of the literature reports of nsp3 HTS campaigns with a focus on the presence of additives and what metal susceptibility was likely, given the results of our work. We conclude that the majority of reported nsp3 screens are susceptible to copper contamination with a smaller proportion also potentially susceptible to palladium contamination.

27 November 2025 in bioRxiv
Verified
Preprint
Open access
IGIrene Georgiou
Irene Georgiou
SOSandra O’NEill
Sandra O’NEill
CRColin Robinson
Colin Robinson
FCFraser Cunningham
Fraser Cunningham
SOSean O'Byrne
Sean O'Byrne
DSDuncan E. Scott
Duncan E. Scott
Different biochemical assays yield different rates of false positives than others either due to the nature of the enzyme, the technology associated with the assay, or properties of the compounds being screened. Ensuring that the right counter-screens are in place to identify false positives without wasting time and resources on them is of great importance. Herein we describe the results of a high throughput screen (HTS) against non-structural protein 3 (nsp3) protease PL Pro , which resulted exclusively in false-positive hits. By triaging hit compounds through purification of metal chelating resin, we identified contamination by either copper or palladium as the most likely source of false positives from the library screening campaign. We then performed a systematic assessment of the vulnerability of nsp3 protease screening to metal contamination and evaluated common additives to combat the inhibitory effects of different metal salts. We further conducted a thorough survey of the literature reports of nsp3 HTS campaigns with a focus on the presence of additives and what metal susceptibility was likely, given the results of our work. We conclude that the majority of reported nsp3 screens are susceptible to copper contamination with a smaller proportion also potentially susceptible to palladium contamination.